chr6-13814297-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001031713.4(MCUR1):āc.133C>Gā(p.Leu45Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000797 in 1,502,432 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001031713.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MCUR1 | NM_001031713.4 | c.133C>G | p.Leu45Val | missense_variant | 1/9 | ENST00000379170.9 | NP_001026883.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MCUR1 | ENST00000379170.9 | c.133C>G | p.Leu45Val | missense_variant | 1/9 | 1 | NM_001031713.4 | ENSP00000368468.3 | ||
MCUR1 | ENST00000488770.1 | n.133C>G | non_coding_transcript_exon_variant | 1/10 | 2 | ENSP00000476162.1 |
Frequencies
GnomAD3 genomes AF: 0.000731 AC: 111AN: 151900Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00124 AC: 122AN: 98358Hom.: 0 AF XY: 0.00109 AC XY: 60AN XY: 55078
GnomAD4 exome AF: 0.000804 AC: 1086AN: 1350424Hom.: 0 Cov.: 34 AF XY: 0.000802 AC XY: 534AN XY: 665864
GnomAD4 genome AF: 0.000730 AC: 111AN: 152008Hom.: 0 Cov.: 32 AF XY: 0.000767 AC XY: 57AN XY: 74316
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 08, 2022 | The c.133C>G (p.L45V) alteration is located in exon 1 (coding exon 1) of the MCUR1 gene. This alteration results from a C to G substitution at nucleotide position 133, causing the leucine (L) at amino acid position 45 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at